Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Cash: 2009-2024

Historic Change in Cash for Sunshine Biopharma (SBFM) over the last 16 years, with Dec 2024 value amounting to -$5.6 million.

  • Sunshine Biopharma's Change in Cash fell 950.21% to -$770,560 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 64.57%. This contributed to the annual value of -$5.6 million for FY2024, which is 7.38% up from last year.
  • As of FY2024, Sunshine Biopharma's Change in Cash stood at -$5.6 million, which was up 7.38% from -$6.0 million recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Change in Cash registered a high of $19.6 million during FY2022, and its lowest value of -$6.0 million during FY2023.
  • Its 3-year average for Change in Cash is $2.7 million, with a median of -$5.6 million in 2024.
  • Its Change in Cash has fluctuated over the past 5 years, first spiked by 1,722.08% in 2022, then plummeted by 130.65% in 2023.
  • Sunshine Biopharma's Change in Cash (Yearly) stood at $949,763 in 2020, then increased by 13.24% to $1.1 million in 2021, then skyrocketed by 1,722.08% to $19.6 million in 2022, then tumbled by 130.65% to -$6.0 million in 2023, then rose by 7.38% to -$5.6 million in 2024.